Back to Search
MEYER GLANTZ, PH.D.
PH.D.
Clinical Psychologist
NPI: 1518155845Individual
Specialties, Licenses & Credentials
Addiction (Substance Use Disorder) Psychologist
Psychologist — Addiction (Substance Use Disorder)
Code: 103TA0400X
01446(MD)
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
01446(MD)
Research & Publications (20)
Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.
PMID 19046473·Psychol Med·2009
8-other
Prenatal drug exposure effects on subsequent vulnerability to drug abuse.
PMID 17152406·Dev Psychopathol·2006
6-review
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.
PMID 18820836·J Neurooncol·2009
3-trial
Statistical and trial design considerations in central nervous system prophylaxis studies.
PMID 19660685·Semin Oncol·2009
6-review
Gender disparity in the rate of partner abandonment in patients with serious medical illness.
PMID 19645027·Cancer·2009
4-observational
Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication.
PMID 18466664·Psychol Med·2009
8-other
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
PMID 19660682·Semin Oncol·2009
6-review
Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey.
PMID 19549055·Addiction·2009
8-other
Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
PMID 19139302·Arch Neurol·2009
8-other
New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer.
PMID 18936791·Nat Clin Pract Oncol·2009
6-review
Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
PMID 19660681·Semin Oncol·2009
2-rct
Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay.
PMID 19660679·Semin Oncol·2009
3-trial
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
PMID 18977094·Int J Radiat Oncol Biol Phys·2009
3-trial
The science of prevention: novel strategies for and new insights into central nervous system prophylaxis in patients with cancer.
PMID 19660678·Semin Oncol·2009
8-other
Is Central Asia the eastern outpost of the Neandertal range? A reassessment of the Teshik-Tash child.
PMID 18711730·Am J Phys Anthropol·2009
7-preclinical
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
PMID 18981465·J Clin Oncol·2008
3-trial
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
PMID 18981882·Neurosurgery·2008
8-other
Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism.
PMID 18719070·J Oncol Pharm Pract·2008
5-case
Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas.
PMID 18756531·Cancer·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6131 EXECUTIVE BLVD
ROCKVILLE, MD 20852 - Phone
- (301) 881-0516
Quick Facts
- NPI
- 1518155845
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile